were rising after the generic-drug maker posted fourth-quarter earnings that jumped 51% from the previous year. Teva was higher by $1.96, or 5.5%, to $37.32.
said it swung to a fourth-quarter loss of $4.9 million, or 8 cents a share. Excluding charges, the company earned $1.06 a share, handily beating estimates. Cephalon, which also upped its full-year forecast, was recently gaining $3.25, or 4.5%, to $75.70.
posted a fourth-quarter profit that slipped 4.6% from the year-ago quarter, hurt by generic alternatives to its blood-thinning drug Plavix. The stock was losing $1.14, or 2.6%, to $43.15.
fell 3.1% after the company posted a fourth-quarter loss that swelled from a year ago. Momenta was recently down 47 cents to $14.50.
Among health care stocks gaining ground,
was rising 7.3% to $25.92;
was gaining 4.6% to $36.55; and
was adding 2.2% to $18.41.
As for decliners,
fell 2.1% to $53.15;
was losing 1.9% to $31.14; and
was off 1.6% to $53.25.